Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Immune Editing Roles of SIGLEC15 in Tumor Microenvironment [scRNA-seq]

ABSTRACT: Immune Editing Roles of SIGLEC15 in Tumor Microenvironment [scRNA-seq]

PROVIDER: PRJNA903802 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22355476_1.fastq.gz	Fastqsanger.gz
	SRR22355476_2.fastq.gz	Fastqsanger.gz
	SRR22355477_1.fastq.gz	Fastqsanger.gz
	SRR22355477_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Immune Editing Roles of SIGLEC15 in Tumor Microenvironment [scRNA-seq]

Project description:SIGLEC15 in tumor microenvironment could dampen cytotoxic functions of T cells, and we blocked SIGLEC15 with mono-antibody to examine functional changes of cell populations in comparison to treatment of IgG.

2024-08-08 | GSE218410 | GEO

Immune Editing Roles of SIGLEC15 in Tumor Microenvironment of Hepatocellular Carcinoma

Project description:Immune Editing Roles of SIGLEC15 in Tumor Microenvironment of Hepatocellular Carcinoma

| PRJNA903797 | ENA

Functional Changes of CD8+ T Cells in Tumor Microenvironment after SIGLEC15 Blockade [bulk RNA-seq]

Project description:To understand how SIGLEC15 regulates CD8+ T cells in tumor microenvironment, we enriched CD8+ T cells using magnetic beads after tumor digestion. Collected CD8+ T cells were examined with flowcytometry analysis and were further loaded for sequencing analysis.

2024-08-08 | GSE218409 | GEO

Immune Editing Roles of SIGLEC15 in Tumor Microenvironment of Hepatocellular Carcinoma

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-08-08 | GSE218411 | GEO

Functional Changes of CD8+ T Cells in Tumor Microenvironment after SIGLEC15 Blockade [bulk RNA-seq]

Project description:Functional Changes of CD8+ T Cells in Tumor Microenvironment after SIGLEC15 Blockade [bulk RNA-seq]

| PRJNA903800 | ENA

UCA remodels tumor microenvironment(scRNA-Seq)

Project description:UCA remodels tumor microenvironment(scRNA-Seq)

| PRJNA1160258 | ENA

Cajanin Transcriptionally Disrupts the Siglec15/NFATc1 Signaling Cascade to Attenuate Osteoclast Fusion and Bone Resorption

Project description:Osteoclast fusion is a critical step for bone resorption, and its dysregulation contributes to pathological bone loss such as postmenopausal osteoporosis. Siglec15, a membrane-bound lectin, has emerged as a key regulator of osteoclast precursor recognition and fusion. Here, we report that Cajanin, a natural small-molecule compound, effectively inhibits osteoclastogenesis and bone resorption both in vitro and in vivo. Cajanin treatment suppressed actin ring formation, bone resorptive activity, and the expression of osteoclastic markers including Ctsk, Mmp9, and c-Fos in a dose-dependent manner. Transcriptomic profiling revealed that Cajanin downregulated key fusion mediators such as Siglec15, DC-STAMP, OC-STAMP, and NFATc1. Gene enrichment analysis identified attenuated MAPK and NFκB signaling, which was validated by decreased phosphorylation of ERK, JNK, and p38, increased IκBα levels, and reduced nuclear translocation of p65. Moreover, Cajanin significantly suppressed NFATc1 expression and nuclear localization. In an ovariectomy-induced bone loss model, Cajanin preserved trabecular bone architecture and reduced TRAP-positive osteoclasts. Collectively, our findings demonstrate that Cajanin transcriptionally disrupts the Siglec15–NFATc1 signaling axis, thereby impairing osteoclast fusion and bone resorption, and highlight its potential as a therapeutic candidate for selectively targeting pathological osteoclast fusion in osteolytic diseases.

2026-09-01 | GSE309318 | GEO

The chromatin remodeling factor Arid1a cooperates with Jun/Fos to promote osteoclastogenesis by epigenetically upregulating Siglec15 expression

Project description:Osteoporosis is characterized by an imbalance between osteoclast-mediated bone resorption and osteoblast-related bone formation, particularly increased osteoclastogenesis. However, the mechanisms by which epigenetic factors regulate osteoclast precursor differentiation during osteoclastogenesis remain poorly understood. Here, we show that the specific knockout of the chromatin remodeling factor Arid1a in bone marrow?derived macrophages (BMDMs) results in increased bone mass. The loss of Arid1a in BMDM inhibits cell?cell fusion and maturation of osteoclast precursors, thereby suppressing osteoclast differentiation. Mechanistically, Arid1a increases the chromatin access in the gene promoter region of sialic acid?binding Ig-like lectin 15 (Siglec15) by transcription factor Jun/Fos, which results in the upregulation of Siglec15 and promotion of osteoclast differentiation. However, the loss of Arid1a reprograms the chromatin structure to restrict Siglec15 expression in osteoclast precursors, thereby inhibiting BMDM differentiation into mature osteoclasts. Deleting Arid1a after ovariectomy (a model for postmenopausal bone loss) alleviated bone loss and maintained bone mass. In summary, epigenetic reprogramming mediated by Arid1a loss suppresses osteoclast differentiation and may serve as a promising therapeutic strategy for treating bone loss diseases.

2024-05-01 | GSE231933 | GEO

Immunosuppressive tumor microenvironment of osteosarcoma [scRNA-seq]

Project description:Immunosuppressive tumor microenvironment of osteosarcoma [scRNA-seq]

| PRJNA1272125 | ENA

Roles of Arx in developing interneuron [scRNA-seq]

Project description:Roles of Arx in developing interneuron [scRNA-seq]

| PRJNA1145447 | ENA